Want to join the conversation?
$MYL 2Q15 Call: We are raising our 2015 adjusted diluted EPS guidance range to 4.15-4.35, an increase of 19% or 23% on a constant currency basis compared to our performance in 2014. Our guidance now excludes any contribution from Generic Copaxone and includes potential generic competition on EpiPen in the second half of the year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?